Tuesday, April 12th @ 12:30 pm ET COPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing
Investegate announcements from Evaxion Biotech, Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personalized Cancer Immunotherapies
Melanoma incidence has been increasing in the United States over the last few decades. Some researchers argue that this is overdiagnosis, fueled by screening, especially among White patients.